✦ LIBER ✦

Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine

✍ Scribed by Joel L. Moake; Christine K. Rudy; Joseph H. Troll; Andrew I. Schafer; Mark J. Weinstein; Noreen M. Colannino; Suchen L. Hong

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 750 KB
Volume: 20
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830200110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic relapsing thrombotic thrombocyto

Chronic relapsing thrombotic thrombocytopenic purpura: Role of therapy with cyclosporine

✍ Pasquale, Donald; Vidhya, Rakesh; DaSilva, Karen; Tsan, Min-Fu; Lansing, Lawrenc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Relapsing thrombotic thrombocytopenic purpura (TTP) is a rare disorder with most individuals experiencing 1 to 5 relapses. We report a patient with 18 episodes of thrombotic thrombocytopenic purpura (TTP), the highest number of relapses thus far described. The last 11 episodes were treated with regi

Effectiveness of cryosupernatant therapy

Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura

✍ G. T. Obrador; Z. R. Zeigler; R. K. Shadduck; C. S. Rosenfeld; J. B. Hanrahan 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 2 views

## Abstract This report describes objective improvement in two patients with poorly responsive thrombotic thrombocytopenic purpura (TTP) syndromes (with cryosupernatant). The first had a partial response to plasma exchange with whole plasma (fresh frozen plasma; FFP) and responded dramatically when

Successful repeat therapy with rituximab

Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura

✍ Wilmar Patino; Ravindra Sarode 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

## Abstract Thrombotic thrombocytopenic purpura (TTP) is a life‐threatening disease that is treated successfully with therapeutic plasma exchange (TPE) and often with corticosteroids; however, almost one third of TTP patients have treatment failures that require either long‐term TPEs or other adjun

Cyclosporine therapy in refractory/relap

Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura

✍ Annamaria Nosari; Rosaria Redaelli; Teresa Maria Caimi; Gianni Mostarda; Enrica 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

To the editor: The interesting article by van Beers et al. states that functional studies does not offer clues as to the presence of mild pulmonary hypertension (PH) in patients with sickle cell disease (SCD) [1]. However, they did show that although not statistically significant, lung function find

Chronic relapsing thrombotic thrombocyto

Chronic relapsing thrombotic thrombocytopenic purpura and antiphospholipid antibodies: A report of two cases

✍ Trent, Kelley; Neustater, Brett R.; Lottenberg, Richard 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

We report on 2 cases of chronic relapsing thrombotic thrombocytopenic purpura, in which anti-phospholipid antibodies were also found. The first patient was felt to have the antiphospholipid antibody syndrome, while the second patient had anti-phospholipid antibodies without clinical manifestations o

Do infections provoke exacerbations and

Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura?

✍ Christine M. Cserti; Stephen Landaw; Lynne Uhl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

## Abstract Several case reports have suggested an association between infections and thrombotic thrombocytopenic purpura (TTP). In Case 1, a 37‐year‐old female presented with TTP 6 times over 7 years, requiring 242 therapeutic plasma exchanges (TPE), for a per‐course range of 4–57 TPE (median 48),